SCHEMBL2879531

SCHEMBL2879531

CCOC(=O)c1ccc(C(F)(F)C(=O)OCC)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 3/20 0.58
CA2 P00918 3/20 0.58
CA12 O43570 2/20 0.58
CA7 P43166 2/20 0.58
CA9 Q16790 2/20 0.58
CA14 Q9ULX7 2/20 0.58
ESR1 P03372 1/20 0.58
ESR2 Q92731 1/20 0.58
LMNA P02545 1/20 0.56
CYP1A2 P05177 1/20 0.56
CYP3A4 P08684 1/20 0.56
MAOA P21397 1/20 0.56
MEN1 O00255 3/20 0.52
KMT2A Q03164 3/20 0.52
TSHR P16473 1/20 0.52
PDK1 Q15118 1/20 0.51
PDK2 Q15119 1/20 0.51
PDK3 Q15120 1/20 0.51
PDK4 Q16654 1/20 0.51
HPGD P15428 4/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13199136 0.91 TSHR (0.49) CA1CA2CA12CA7CA9
SCHEMBL12003891 0.88 MAOB (0.47) CA1CA2CA12CA7CA9
SCHEMBL12004362 0.88 SRD5A2 (0.47) CA1CA2CA12CA7CA9
SCHEMBL12019025 0.86 HDAC4 (0.47) CA1CA2CA12CA7CA9
SCHEMBL15942603 0.86 CA1 (0.58) CA1CA2CA12CA7CA9
SCHEMBL5003336 0.86 NPSR1 (0.47) LMNAKMT2ATSHRHTTSMN1; SMN2
SCHEMBL13199166 0.86 TSHR (0.46) LMNAMEN1KMT2ATSHRPDK2
SCHEMBL17583195 0.86 NPSR1 (0.51) CYP1A2MEN1KMT2ATSHRMAPT
SCHEMBL668192 0.86 CA12 (0.61) CA1CA2CA12CA7CA9
SCHEMBL31306426 0.84 CA12 (0.55) CA1CA2CA12CA7CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8802886-B2 Method for producing aromatic difluoroacetic acid ester CENTRAL GLASS COMPANY, LIMITED (JP) 2014-08-12 US disclosed
US-8802886-B2 Method for producing aromatic difluoroacetic acid ester CENTRAL GLASS COMPANY, LIMITED (JP) 2014-08-12 US disclosed
EP-2502898-A1 PREPARATION METHOD FOR AROMATIC DIFLUOROACETIC ACID ESTER Central Glass Company, Limited (JP) 2012-09-26 EP disclosed
US-20120220795-A1 METHOD FOR PRODUCING AROMATIC DIFLUOROACETIC ACID ESTER CENTRAL GLASS COMPANY, LIMITED (JP) 2012-08-30 US disclosed
US-20100216758-A1 Pyridone Compounds MSD K.K. (JP) 2010-08-26 US disclosed
EP-1916239-A1 PYRIDONE COMPOUND BANYU PHARMACEUTICAL CO., LTD. (JP) 2008-04-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100216758-A1 Pyridone Compounds NPY1R, MC5R, MC1R CA1 4878/4885CA2 4358/4885CA12 4875/4885
US-20120220795-A1 METHOD FOR PRODUCING AROMATIC DIFLUOROACETIC ACID ESTER DDC, AADAC, FNTB CA1 115/4885CA2 184/4885CA12 256/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.